Current Liabilities

Current Debt

Royalty Pharma Current Debt remained flat by 0.0% to $380.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 61.9%, from $998.61M to $380.00M. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalLower is better
VolatilityModerate
First reportedQ4 2019
Last reportedQ1 2026

How to read this metric

An increase signals higher near-term cash requirements for debt service, potentially impacting liquidity.

Detailed definition

This represents the portion of long-term debt obligations that are scheduled to mature and require repayment within the...

Peer comparison

Standard metric for companies with significant capital structures; peers with higher leverage will show larger balances.

Metric ID: current_portion_long_term_debt

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$0.00$0.00$0.00$0.00$0.00$996.58M$997.51M$998.44M$999.37M$0.00$0.00$0.00$0.00$996.94M$997.77M$998.61M$999.44M$380.00M$380.00M$380.00M
QoQ Change+0.1%+0.1%+0.1%-100.0%+0.1%+0.1%+0.1%-62.0%+0.0%+0.0%
YoY Change-100.0%-100.0%-100.0%-100.0%-61.9%-61.9%-61.9%
Range$0.00$999.44M
Avg YoY Growth-83.7%
Median YoY Growth-100.0%
Current Streak2 quarters growth

Frequently Asked Questions

What is Royalty Pharma's current debt?
Royalty Pharma (RPRX) reported current debt of $380.00M in Q1 2026.
How has Royalty Pharma's current debt changed year-over-year?
Royalty Pharma's current debt decreased by 61.9% year-over-year, from $998.61M to $380.00M.
What does current debt mean?
The part of long-term debt that must be paid back within the next year.